119 related articles for article (PubMed ID: 24927708)
1. The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging.
Mato Abad V; Quirós A; García-Álvarez R; Loureiro JP; Alvarez-Linera J; Frank A; Hernández-Tamames JA
J Alzheimers Dis; 2014; 42(3):801-11. PubMed ID: 24927708
[TBL] [Abstract][Full Text] [Related]
2. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
Waragai M; Hata S; Suzuki T; Ishii R; Fujii C; Tokuda T; Arai H; Ohrui T; Higuchi S; Yoshida M; Igarashi K; Moriya M; Iwai N; Uemura K
J Alzheimers Dis; 2014; 41(4):1207-22. PubMed ID: 24787913
[TBL] [Abstract][Full Text] [Related]
3. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
[TBL] [Abstract][Full Text] [Related]
5. Morphometric network differences in ageing versus Alzheimer's disease dementia.
Pichet Binette A; Gonneaud J; Vogel JW; La Joie R; Rosa-Neto P; Collins DL; Poirier J; Breitner JCS; Villeneuve S; Vachon-Presseau E; ;
Brain; 2020 Feb; 143(2):635-649. PubMed ID: 32040564
[TBL] [Abstract][Full Text] [Related]
6. Multivariate statistical analysis of diffusion imaging parameters using partial least squares: Application to white matter variations in Alzheimer's disease.
Konukoglu E; Coutu JP; Salat DH; Fischl B;
Neuroimage; 2016 Jul; 134():573-586. PubMed ID: 27103138
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
8. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
[TBL] [Abstract][Full Text] [Related]
9. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
10. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Pina MA
Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
[TBL] [Abstract][Full Text] [Related]
11. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease.
Acosta O; Fripp J; Doré V; Bourgeat P; Favreau JM; Chételat G; Rueda A; Villemagne VL; Szoeke C; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Bonner E; Gris F; Xiao D; Raniga P; Barra V; Salvado O
J Neurosci Methods; 2012 Mar; 205(1):96-109. PubMed ID: 22226742
[TBL] [Abstract][Full Text] [Related]
12. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
[TBL] [Abstract][Full Text] [Related]
13. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2010; 30(1):71-7. PubMed ID: 20689286
[TBL] [Abstract][Full Text] [Related]
14. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic magnetic resonance imaging of the brain: voxel localisation and tissue segmentation in the follow up of brain tumour.
Poloni G; Bastianello S; Vultaggio A; Pozzi S; Maccabelli G; Germani G; Chiarati P; Pichiecchio A
Funct Neurol; 2008; 23(4):207-13. PubMed ID: 19331784
[TBL] [Abstract][Full Text] [Related]
16. Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.
Zhu X; Cao L; Hu X; Dong Y; Wang H; Liu F; Sun Z
Clin Neurol Neurosurg; 2015 Mar; 130():80-5. PubMed ID: 25590663
[TBL] [Abstract][Full Text] [Related]
17. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease.
Zhong X; Shi H; Shen Z; Hou L; Luo X; Chen X; Liu S; Zhang Y; Zheng D; Tan Y; Huang G; Fang Y; Zhang H; Mu N; Chen J; Wu R; Ning Y
J Alzheimers Dis; 2014; 40(4):953-66. PubMed ID: 24531156
[TBL] [Abstract][Full Text] [Related]
18. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
[TBL] [Abstract][Full Text] [Related]
19. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
[TBL] [Abstract][Full Text] [Related]
20. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
